SGLT2 inhibitors – MIMS – Reminder of the associated risk of diabetic ketoacidosis
01/12/2022
Medicines for human use
Safety update
This article was produced by the HPRA for publication in the December edition of Monthly Index of Medical Specialties (MIMS) and describes the associated risk of diabetic ketoacidosis with SGLT2 inhibitors.